Primary mediastinal large B-cell lymphoma.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Treatment Reviews

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ctrv.2015.04.006PMID 25913715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67 Gallium Scan in 50 Patients

  2016influential reference
• PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

  2015cited by this paper
• Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

  2015cited by this paper
• Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

  2015cited by this paper
• Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease

  2014influential reference
• Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

  2014cited by this paper
• Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

  2014cited by this paper
• Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

  2014cited by this paper
• Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies

  2014cited by this paper
• [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

  2014cited by this paper
• Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

  2014cited by this paper
• Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

  2014cited by this paper
• Primary Mediastinal Large B-cell Lymphoma

  2014cited by this paper
• The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma

  2014influential reference
• Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

  2013cited by this paper
• Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

  2013cited by this paper
• Preclinical Analyses Of The Chemical JAK2 Inhibitor, SAR302503, In Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

  2013cited by this paper
• Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy.

  2013influential reference
• Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.

  2013cited by this paper
• Primary mediastinal large B-cell lymphoma segregating in a family : exome sequencing identi fi es MLL as a candidate predisposition gene

  2013cited by this paper
• Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.

  2013cited by this paper
• Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene.

  2013cited by this paper
• Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

  2013cited by this paper
• Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab

  2013cited by this paper
• Therapy in primary mediastinal B-cell lymphoma.

  2013cited by this paper
• Dosimetric Evaluation and Treatment Outcome of Intensity Modulated Radiation Therapy After Doxorubicin-Based Chemotherapy for Primary Mediastinal Large B-Cell Lymphoma

  2013influential reference
• A Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory CD30-Positive Non-Hodgkin Lymphomas: Interim Results In Patients With DLBCL and Other B-Cell Lymphomas

  2013cited by this paper
• Obinutuzumab (GA101), a Novel Type II Glycoengineered CD20 Antibody, Significantly Induced Programmed Cell Death In Primary Mediastinal B-Cell Lymphoma (PMBL): Obinutuzumab May Be a Future Potential Targeted Agent For The Treatment Of PMBL

  2013cited by this paper
• Overexpression Of Deleted In Lymphocytic Leukemia 1 (DLEU1) Significantly Induces Programmed Cell Death and Inhibits Cell Proliferation In Primary Mediastinal B-Cell Lymphoma (PMBL): DLEU1 May Be a Tumor Suppressor Gene In a Subset Of Patients With PMBL

  2013cited by this paper
• Population Outcomes Of Primary Mediastinal Large B-Cell Lymphoma In The Rituximab Era

  2013influential reference
• Therapy in primary mediastinal B-cell lymphoma.

  2013cited by this paper
• Therapy in primary mediastinal B-cell lymphoma.

  2013cited by this paper
• Novel Prognostic Model Of Primary Mediastinal Large B-Cell Lymphoma (PMBL): A Multicenter Cooperative Retrospective Study In Japan

  2013influential reference
• Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers

  2012cited by this paper
• JAK1/JAK2 Inhibitor, Ruxolitinib Inhibits Cell Proliferation and Induces Apoptosis in Hodgkin Lymphomas (HL) and Primary Mediastinal B-Cell Lymphomas (PMBL)

  2012cited by this paper
• The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

  2012influential reference
• Interim PET Scan Does Not Predict Outcome in Primary Mediastinal B Cell Lymphoma Treated with R DA EPOCH

  2012influential reference
• Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

  2012influential reference
• Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).

  2012influential reference
• Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients

  2011influential reference
• The molecular pathogenesis of primary mediastinal large B-cell lymphoma.

  2011influential reference
• Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?

  2011cited by this paper
• Lymphoblastic lymphoma.

  2011cited by this paper
• Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.

  2011influential reference
• Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma

  2011cited by this paper
• Aggressive lymphomas.

  2010cited by this paper
• Early-stage Hodgkin's lymphoma.

  2010cited by this paper
• Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

  2010influential reference
• Cooperative epigenetic modulation by cancer amplicon genes.

  2010cited by this paper
• Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

  2010cited by this paper
• Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

  2008cited by this paper
• Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.

  2008cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

  2007cited by this paper
• Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)

  2007cited by this paper
• Primary mediastinal large B-cell lymphoma.

  2006cited by this paper
• Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

  2006cited by this paper
• Relapsed and Refractory Primary Mediastinal Diffuse Large B-Cell Lymphoma: Outcome with ICE-Based Treatment.

  2006cited by this paper
• Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

  2005cited by this paper
• Primary mediastinal large B‐cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at memorial Sloan Kettering from 1980 to 1999

  2005cited by this paper
• Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B

  2004influential reference
• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

  2003cited by this paper
• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  2003influential reference
• Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

  2003cited by this paper
• Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.

  2002influential reference
• Primary Mediastinal Large B-Cell Lymphoma: A Comparative Study With Nodular Sclerosis—Type Hodgkin’s Disease

  2001cited by this paper
• Primary mediastinal B-cell lymphoma: a review of pathology and management.

  2001cited by this paper
• Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.

  1999influential reference
• CNS involvement in primary mediastinal large B-cell lymphoma.

  1999influential reference
• New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

  1998influential reference
• Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

  1998cited by this paper
• MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis.

  1998cited by this paper
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

  1997cited by this paper
• A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project

  1997cited by this paper
• Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.

  1997influential reference
• Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.

  1996cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.

  1993influential reference
• Primary mediastinal non-Hodgkin's lymphomas: a morphologic and immunologic study of 19 cases.

  1985cited by this paper
• Primary Non‐Hodgkin's lymphoma of the mediastinum

  1982cited by this paper
• Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction

  1981cited by this paper

• Flow Cytometry for B-Cell Non-Hodgkin and Hodgkin Lymphomas

  2025influential citation
• Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study

  2025cites this paper
• CD19 CAR T‐Cell Therapy for Primary Mediastinal Large B‐Cell Lymphoma: A CIBMTR Analysis

  2025cites this paper
• Primary Mediastinal Large B-cell Lymphoma: A Diagnostic Conundrum

  2025influential citation
• Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New

  2025cites this paper
• Insidious Primary Mediastinal Large B-Cell Lymphoma in a Young Female: A Case Report and Literature Review

  2025cites this paper
• Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience

  2025cites this paper
• The value of radiomics features of the spleen as surrogates for differentiating subtypes of common pediatric lymphomas

  2024cites this paper
• Primary Mediastinal Large B-cell Lymphoma From the Clinic to Genomics: Insights for Pathologists.

  2024cites this paper
• Current knowledge and management of primary mediastinal large B-cell lymphoma

  2024cites this paper
• Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment

  2024cites this paper
• Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

  2024cites this paper
• PD-1 inhibitor in the treatment of relapsed primary mediastinal large B-cell lymphoma follow up by 18F-FDG PET/CT: A case report and literature review

  2024cites this paper
• Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification

  2024cites this paper
• Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art

  2024cites this paper
• Isolated central nervous system relapse in two adolescents with primary mediastinal large B‐cell lymphoma after treatment with R‐DA‐EPOCH

  2024cites this paper
• The combination of maximum standardized uptake value and clinical parameters for improving the accuracy in distinguishing primary mediastinal lymphomas from thymic epithelial tumors

  2024cites this paper
• Classification of B-Cell Lymphomas and Immunodeficiency-Related Lymphoproliferations: What’s New?

  2023cites this paper
• Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma

  2023cites this paper
• Primary Mediastinal B-Cell Lymphoma Presenting as Cardiac Tamponade

  2023cites this paper
• Large retrosternal non-hodgkin’s lymphoma presenting with recurrent syncope episodes and chest asymmetry: A case report

  2023cites this paper
• Genetic Factors in Familial Manifestation of Primary Mediastinal Large B-Cell Lymphoma over Two Generations

  2023cites this paper
• Primary mediastinal large B-cell lymphoma that occurs in an unexpected localization

  2023cites this paper
• A case of suspected primary mediastinal large B-cell lymphoma: An uncommon cause of sudden death.

  2023cites this paper
• Fatal anterior mediastinal mass in a pregnant lady

  2023cites this paper
• Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival

  2023cites this paper
• Complicaciones cardiovasculares en gestante con linfoma primario mediastinal de células B

  2022cites this paper
• Proton Radiotherapy Following Chemotherapy in the Management of Aggressive Mediastinal non-Hodgkin Lymphomas: A PTCOG Lymphoma Subcommittee Collaboration

  2022cites this paper
• Treatment Selection and Survival in Patients with Gray Zone Lymphoma: A Comprehensive Population-Based Analysis.

  2022cites this paper
• Outcome of diffuse large B-cell lymphoma patients treated with different chemotherapeutic regimens (R-DA-EPOCH vs R-CHOP)

  2022cites this paper
• Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings

  2022cites this paper
• Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma

  2022cites this paper
• Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience

  2021cites this paper
• Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

  2021cites this paper
• Primary mediastinal large B-cell lymphoma

  2021cites this paper
• Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)

  2021cites this paper
• Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.

  2021cites this paper
• Development of scalable lymphatic system in the 4D XCAT phantom: application to quantitative evaluation of lymphoma PET segmentations.

  2021cites this paper
• Molecular Update and Evolving Classification of Large B-Cell Lymphoma

  2021cites this paper
• Mediastinal Lymphoproliferative Disorders

  2021cites this paper
• Antibody Therapies for Large B-Cell Lymphoma

  2021cites this paper
• IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL

  2021cites this paper
• Lymphoma Masquerading as an Ear Mass

  2021cites this paper
• Mediastinal diffuse large B-cell lymphoma mimicking invasive thymoma on 68Ga-FAPI PET/CT

  2021cites this paper
• Surgical considerations for tension hydrothorax in primary mediastinal B-cell lymphoma: A case report

  2021influential citation
• Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States

  2021cites this paper
• Flow cytometric immunophenotyping in a liquid‐based cytology sample of pleural fluid: Connecting the dots

  2021cites this paper
• Expecting the unexpected – Primary mediastinal large B cell lymphoma presenting as huge lung parenchymal mass

  2021cites this paper
• Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices

  2020influential citation
• Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma

  2020cites this paper
• Tumor-regulated macrophage type 2 differentiation promotes immunosuppression in laryngeal squamous cell carcinoma.

  2020cites this paper
• Coriocarcinoma de mediastino anterior en paciente masculino.

  2020cites this paper
• Case Study: Management of a patient with Primary Mediastinal B-cell Lymphoma (PMBL)

  2020cites this paper
• Pembrolizumab in relapsed or refractory Richter syndrome

  2020cites this paper
• Clinicoepidemiological profile of extranodal lymphoma: The experience of a tertiary care center in India

  2020cites this paper
• Radiogenomics and Its Role in Lymphoma

  2020cites this paper
• Treatment of relapsed/refractory paediatric aggressive B‐cell non‐Hodgkin lymphoma

  2020cites this paper
• The Thorax

  2020cites this paper
• Primary Mediastinal Large B-Cell Lymphoma

  2020cites this paper
• Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma

  2020cites this paper
• Primary mediastinal large B-cell lymphoma

  2019cites this paper
• The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.

  2019cites this paper
• Results of multicenter international trail for pediatric primary mediastinal B-cell lymphoma treated according to protocols B-NHL-M-10 and DA-EPOCH-R

  2019cites this paper
• Mediastinal Lymphoma Presenting in Cardiogenic Shock with Superior Vena Cava Syndrome in a Primigravida at Full Term: Salvage Resection after Prolonged Extracorporeal Life Support

  2019cites this paper
• Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma

  2019cites this paper
• Case 7004 Non-Hodgkin ' s Lymphoma mimicking Bronchogenic Carcinoma

  2019cites this paper
• Primary Mediastinal Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up

  2019influential citation
• Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1

  2019cites this paper
• Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2

  2019cites this paper
• Lymphoproliferative Disorders

  2019cites this paper
• A PRIMARY THYMIC NON HODGKIN LYMPHOMA: A RARE MEDIASTINAL MASS

  2019cites this paper
• Epidemiological Characteristics of Non-Hodgkin Lymphoma in Clinical Oncology and Nuclear Medicine Department in Zagazig University Hospitals (2013-2017)

  2019cites this paper
• Atypical chronic myeloid leukemia: a rare entity with management challenges.

  2018cites this paper
• Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma

  2018cites this paper
• R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis

  2018cites this paper
• Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin’s lymphoma and primary mediastinal B-cell lymphoma

  2018cites this paper
• Thymic Tumors and Lymphomas: The Clinical Impact of Their Underlying Molecular Features

  2018cites this paper
• Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

  2018cites this paper
• Editorial on “Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016”

  2018influential citation
• Management of Primary Mediastinal B-Cell Lymphoma in Pregnancy

  2018cites this paper
• A perplexing primary novel hilar lesion: Remember the pneumonic PPNHL!

  2018cites this paper
• PDCD1LG2 (PD‐L2) RNA in situ hybridization is a sensitive, specific, and practical marker of primary mediastinal large B‐cell lymphoma

  2018cites this paper
• Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model

  2018cites this paper
• Primary mediastinal large B‐cell lymphoma: Outcome of a series of pediatric patients treated with high‐dose methotrexate and cytarabine plus anti‐CD20

  2018cites this paper
• Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.

  2017cites this paper
• Treatment of a Myocardial Infiltrating Mediastinal Diffuse Large B-cell Lymphoma : A Case Report

  2017cites this paper
• Treatment delays due to similarities between advanced malignant lymphoma and musculoskeletal neoplasms: Report of two adolescent cases

  2017cites this paper
• Discovery and application of immune biomarkers for hematological malignancies

  2017cites this paper
• Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

  2017cites this paper
• The Pathobiology and Treatment of Hodgkin Lymphoma. Where do We go from Gianni Bonadonna's Lesson?

  2017cites this paper
• Second cancer incidence in primary mediastinal B‐cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of l

  2017cites this paper
• Perioperative Considerations for Chylothorax.

  2017cites this paper
• Left ventricular rigid body rotation in a diffuse large B-cell lymphoma patient with cardiac involvement: A case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

  2017cites this paper
• Mature aggressive B-cell lymphoma across age groups – molecular advances and therapeutic implications

  2017cites this paper
• Advances in Diagnosis and Management of Diffuse Large B‐cell Lymphoma

  2017influential citation
• Cytologic perspectives on neoteric B‐cell lymphoproliferative disorders

  2017cites this paper
• Recurrent Genetic Mutations in Lymphoid Malignancies

  2017cites this paper
• Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.

  2017cites this paper
• A Rare Late Complication of Port Catheter Implantation: Embolization of the Catheter

  2017cites this paper
• Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma

  2016cites this paper